Chemotherapy, Bevacizumab, and/or Atezolizumab for Patients With dMMR or MSI-H Metastatic Colorectal Cancer, the COMMIT Study

Clinicaltrials.gov identifier:
NCT02997228

TALAVE: Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

Clinicaltrials.gov identifier:
NCT03964532

Treatment:

Breast

Screening for Pancreatic Cancer in Patients with an Inherited BRCA1, BRCA2, PALB2 or ATM Mutation

Clinicaltrials.gov identifier:
NCT02478892

Prevention:

Pancreatic

Research Study to Help Improve Family Communication About Inherited BRCA1 or BRCA2 Mutations

Prevention:

Breast, Ovarian, Pancreatic, Prostate

TALAPRO-2: A Study Assessing the Study Drug + Enzalutamide vs. Placebo + Enzalutamide in Men With Metastatic Castration Resistant Prostate Cancer (mCRPC) and DNA Damage Repair (DDR) Deficiency

Clinicaltrials.gov identifier:
NCT03395197

Treatment:

Prostate

Phase 1 Study of Oral Drug PMD-026 in People With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

Clinicaltrials.gov identifier:
NCT04115306

Treatment:

Breast

Pembrolizumab Plus Lenvatinib Versus Chemotherapy for Endometrial Cancer

Clinicaltrials.gov identifier:
NCT03884101

Treatment:

Endometrial

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Clinicaltrials.gov identifier:
NCT04042831

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer or Checkpoint Inhibitor Relapsed Tumors

Clinicaltrials.gov identifier:
NCT03775850

Treatment:

Breast, Colorectal, Endometrial

Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer (MOUNTAINEER)

Clinicaltrials.gov identifier:
NCT03043313

Treatment:

Colorectal

Nivolumab, Nivolumab Plus Ipilimumab, or Chemotherapy for Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (CheckMate 8HW)

Clinicaltrials.gov identifier:
NCT04008030

Treatment:

Colorectal

A Study of Melphalan, BCNU, Vitamin B12b, Vitamin C, and Stem Cell Infusion in People with Advanced Pancreatic Cancer and BRCA Mutations

Clinicaltrials.gov identifier:
NCT04150042

Treatment:

Pancreatic

Pembrolizumab and Olaparib for Metastatic Pancreatic Cancer with Homologous Recombination Deficiency or Exceptional Response to Platinum Chemotherapy

Clinicaltrials.gov identifier:
NCT04666740

Parenting Adolescent-Aged Children While Managing a Parental Cancer Diagnosis – Share Your Story

A Survey on Options for Managing Cancer Risk Among Women with a BRCA1 or BRCA2 Mutation

Nous-209 Genetic Vaccine for the Treatment of MSI-H Colorectal, Gastric and Gastro-esophageal junction Tumors

Clinicaltrials.gov identifier:
NCT04041310

Treatment:

Colorectal

Addition of Pembrolizumab to Radiation Treatment for Newly Diagnosed Early Stage MSI-High Endometrial Cancer

Clinicaltrials.gov identifier:
NCT04214067

Treatment:

Endometrial

A Survey on Mothers and Young-Adult Daughters Coping with Breast Cancer Together

TRITON3- Rucaparib vs. Physician Choice for Castration Resistant Prostate Cancer

Clinicaltrials.gov identifier:
NCT02975934

Treatment:

Prostate

A Study to Compare Two Surgical Procedures in Women with BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer (SOROCk)

Clinicaltrials.gov identifier:
NCT04251052

Prevention:

Ovarian

Blood Tests to Measure Ovarian Reserves in Women with a BRCA Mutation or Women Treated for Early-Stage Breast Cancer

Clinicaltrials.gov identifier:
NCT0823654

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor

Olaparib Expanded - Treating Metastatic Breast Cancer in People without gBRCA Mutations

Clinicaltrials.gov identifier:
NCT03344965

Treatment:

Breast

Survey Examining the Relationship Between Communication, Cancer Treatment, and Fertility

The Risk Factor Analysis of Hereditary Breast and Ovarian Cancer In Women with BRCA1, BRCA2 or PALB2 Mutations

PARP Inhibitor for Metastatic Prostate Cancer With DNA Repair Defects

Clinicaltrials.gov identifier:
NCT03012321

Treatment:

Prostate

The Experiences and Needs of People With a Variant of Uncertain Significance (VUS) on Genetic Tests for Hereditary Cancer Risk

Prostate Cancer Genetic Risk, Experience, and Support Study (PROGRESS)

Combination Immunotherapies in Patients Who Previously Received Immune Checkpoint Inhibitors (QUILT-3.055)

Clinicaltrials.gov identifier:
NCT03228667

Treatment:

Colorectal, Melanoma

Diagnosis of Breast Cancer in Young Women - Share Your Story

Studying a Combination of Immunotherapies and Biomarker for Advanced Solid Tumors

Clinicaltrials.gov identifier:
NCT03668119

Treatment:

Breast, Ovarian, Pancreatic, Prostate, Colorectal, Endometrial

PARP Inhibitor for Metastatic Breast Cancer with an Acquired BRCA1 or BRCA2 Mutation Found by Liquid Biopsy

Clinicaltrials.gov identifier:
NCT03990896

Treatment:

Breast

A Study of Nivolumab in Selected Uterine Cancer Patients

Clinicaltrials.gov identifier:
NCT03241745

Treatment:

Endometrial

GENERATE

Clinicaltrials.gov identifier:
NCT03762590

Prevention:

Pancreatic

PARP Inhibitor Alone or Plus Immunotherapy for Advanced BRCA-Associated Breast Cancer

Clinicaltrials.gov identifier:
NCT02849496

Treatment:

Breast

A Randomized Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Breast, Ovarian, Prostate and Pancreatic Cancer Patients (E-Reach)

Clinicaltrials.gov identifier:
NCT04353973

Treatment:

Breast, Ovarian, Pancreatic, Prostate

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Clinicaltrials.gov identifier:
NCT02912559

Treatment:

Colorectal

PHACT Study

Prevention:

Breast, Ovarian, Prostate, Pancreatic, Melanoma

Men at High Genetic Risk for Prostate Cancer

Clinicaltrials.gov identifier:
NCT03805919

Prevention:

Prostate

Genetic Testing for Men with Metastatic Prostate Cancer (GENTleMEN Study)

Clinicaltrials.gov identifier:
NCT03503097

Treatment:

Prostate

Metastatic Prostate Cancer Project

Genetic Education for Men (GEM Study)

Prevention:

Prostate, Pancreatic

CheckMate-9KD for Men with Metastatic Prostate Cancer

Clinicaltrials.gov identifier:
NCT03338790

Treatment:

Prostate

The Metastatic Breast Cancer Project

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Clinicaltrials.gov identifier:
NCT03327103

Treatment:

Prostate

Quality of Life:

Prostate Cancer Survivor

Olaparib Plus DNA Damage Repair Targeted Therapy for Metastatic TNBC

Clinicaltrials.gov identifier:
NCT03330847

Treatment:

Breast

Olive Oil for High Risk Breast Cancer Prevention

Clinicaltrials.gov identifier:
NCT02068092

Prevention:

Breast

Pancreatic Cancer Screening Study for High Risk People

Clinicaltrials.gov identifier:
NCT03250078

Prevention:

Pancreatic

Acupressure to Self-Manage Aromatase Inhibitor Musculoskeletal Symptoms in Breast Cancer Survivors

Clinicaltrials.gov identifier:
NCT03697200

Quality of Life:

Breast Cancer Survivor

Denosumab and Mammographic Density in Premenopausal Women With Dense Breasts (TRIDENT)

Clinicaltrials.gov identifier:
NCT04067726

Prevention:

Breast

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)

Clinicaltrials.gov identifier:
NCT03992131

Treatment:

Breast, Ovarian, Prostate

Connect My Variant

Study of Safety and Effectiveness of Motiva® Breast Implants

Clinicaltrials.gov identifier:
NCT03579901

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor

Study for People with Unexpected Genetic Results

Clinicaltrials.gov identifier:
NCT02595957

Prevention:

Breast, Ovarian, Pancreatic, Prostate

A Study to Evaluate Rucaparib in Patients with Solid Tumors and with Deleterious Mutations in HRR Genes

Clinicaltrials.gov identifier:
NCT04171700

Treatment:

Breast, Ovarian, Pancreatic, Prostate

Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

Clinicaltrials.gov identifier:
NCT03572374

Quality of Life:

Breast Cancer Survivor

Breast Cancer Treatment in Women with PALB2 Mutations

ELLIE's Project

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor, Pancreatic Cancer Survivor, Melanoma Cancer Survivor

INTERVAL: INTense Exercise foR surVivAL in Men With Metastatic Prostate Cancer

Clinicaltrials.gov identifier:
NCT02730338

Quality of Life:

Prostate Cancer Survivor

RADCOMP: A Study at the Heart of Breast Cancer Treatment

Clinicaltrials.gov identifier:
NCT02603341

Treatment:

Breast

Find My Variant

IMPRES - Improving Memory after RRSO

Clinicaltrials.gov identifier:
NCT03187353

Quality of Life:

High Risk But No Cancer, Breast Cancer Survivor, Ovarian Cancer Survivor

Pancreatic Cancer Early Detection

Clinicaltrials.gov identifier:
NCT02206360

Prevention:

Pancreatic

Identification and Analysis of Families With Genetic Susceptibility To Cancer Registry

WISDOM Study

Clinicaltrials.gov identifier:
NCT02620852

Prevention:

Breast

PROMPT

Clinicaltrials.gov identifier:
NCT02665195

Serum Folate in Patients Treated with Olaparib

Clinicaltrials.gov identifier:
NCT04024254

Treatment:

Breast, Ovarian

Talazoparib Beyond BRCA (TBB) Trial

Clinicaltrials.gov identifier:
NCT02401347

Treatment:

Breast

Long-Term Survivors of Ovarian Cancer (LTSOC)

Clinicaltrials.gov identifier:
NCT02321735

Quality of Life:

Ovarian Cancer Survivor